Home > Research > Publications & Outputs > Role of the C-terminal actin binding domain in ...
View graph of relations

Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance. / Underhill-Day, N.; Pierce, Andrew; Thompson, Suzanne et al.
In: British Journal of Haematology, Vol. 132, No. 6, 03.2006, p. 774-783.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Underhill-Day, N, Pierce, A, Thompson, S, Xenaki, D, Whetton, AD & Owen-Lynch, PJ 2006, 'Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance.', British Journal of Haematology, vol. 132, no. 6, pp. 774-783. https://doi.org/10.1111/j.1365-2141.2005.05949.x

APA

Underhill-Day, N., Pierce, A., Thompson, S., Xenaki, D., Whetton, A. D., & Owen-Lynch, P. J. (2006). Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance. British Journal of Haematology, 132(6), 774-783. https://doi.org/10.1111/j.1365-2141.2005.05949.x

Vancouver

Underhill-Day N, Pierce A, Thompson S, Xenaki D, Whetton AD, Owen-Lynch PJ. Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance. British Journal of Haematology. 2006 Mar;132(6):774-783. doi: 10.1111/j.1365-2141.2005.05949.x

Author

Underhill-Day, N. ; Pierce, Andrew ; Thompson, Suzanne et al. / Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance. In: British Journal of Haematology. 2006 ; Vol. 132, No. 6. pp. 774-783.

Bibtex

@article{aac84eb4f191431ca15cf783f14f47a8,
title = "Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance.",
abstract = "Philadelphia chromosome-positive, chronic myeloid leukaemia (CML) stem and progenitor cells have a survival and growth advantage compared with their normal counterparts. The mechanisms through which the BCR/ABL protein tyrosine kinase (PTK) induces these effects and the important domains within this protein are not fully defined. The F- and G-actin binding region of the BCR/ABL C-terminus may be important in BCR/ABL-mediated events, and we have investigated this by expressing a C-terminus deletion mutant of the temperature-sensitive BCR/ABL PTK, in a haemopoietic progenitor cell line, which models the chronic phase of CML. The truncated BCR/ABL PTK displayed similar levels of PTK activity when compared with wild type and activation of second messenger formation (in the form of sn-1,2-diacylglycerol) remains intact. On fibronectin substrata, localisation of the protein to the periphery of the cell was, however, dependent on the C-terminus of BCR/ABL PTK. Deletion of the C-terminus reversed both BCR/ABL-mediated apoptotic suppression and drug resistance although the progenitor cells did retain a proliferative advantage at low concentrations of growth factor. These results demonstrated that the C-terminal actin-binding domain of BCR/ABL is important for some of BCR/ABL PTK-mediated leukaemogenic effects.",
author = "N. Underhill-Day and Andrew Pierce and Suzanne Thompson and D. Xenaki and Whetton, {A. D.} and Owen-Lynch, {P. Jane}",
year = "2006",
month = mar,
doi = "10.1111/j.1365-2141.2005.05949.x",
language = "English",
volume = "132",
pages = "774--783",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "6",

}

RIS

TY - JOUR

T1 - Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance.

AU - Underhill-Day, N.

AU - Pierce, Andrew

AU - Thompson, Suzanne

AU - Xenaki, D.

AU - Whetton, A. D.

AU - Owen-Lynch, P. Jane

PY - 2006/3

Y1 - 2006/3

N2 - Philadelphia chromosome-positive, chronic myeloid leukaemia (CML) stem and progenitor cells have a survival and growth advantage compared with their normal counterparts. The mechanisms through which the BCR/ABL protein tyrosine kinase (PTK) induces these effects and the important domains within this protein are not fully defined. The F- and G-actin binding region of the BCR/ABL C-terminus may be important in BCR/ABL-mediated events, and we have investigated this by expressing a C-terminus deletion mutant of the temperature-sensitive BCR/ABL PTK, in a haemopoietic progenitor cell line, which models the chronic phase of CML. The truncated BCR/ABL PTK displayed similar levels of PTK activity when compared with wild type and activation of second messenger formation (in the form of sn-1,2-diacylglycerol) remains intact. On fibronectin substrata, localisation of the protein to the periphery of the cell was, however, dependent on the C-terminus of BCR/ABL PTK. Deletion of the C-terminus reversed both BCR/ABL-mediated apoptotic suppression and drug resistance although the progenitor cells did retain a proliferative advantage at low concentrations of growth factor. These results demonstrated that the C-terminal actin-binding domain of BCR/ABL is important for some of BCR/ABL PTK-mediated leukaemogenic effects.

AB - Philadelphia chromosome-positive, chronic myeloid leukaemia (CML) stem and progenitor cells have a survival and growth advantage compared with their normal counterparts. The mechanisms through which the BCR/ABL protein tyrosine kinase (PTK) induces these effects and the important domains within this protein are not fully defined. The F- and G-actin binding region of the BCR/ABL C-terminus may be important in BCR/ABL-mediated events, and we have investigated this by expressing a C-terminus deletion mutant of the temperature-sensitive BCR/ABL PTK, in a haemopoietic progenitor cell line, which models the chronic phase of CML. The truncated BCR/ABL PTK displayed similar levels of PTK activity when compared with wild type and activation of second messenger formation (in the form of sn-1,2-diacylglycerol) remains intact. On fibronectin substrata, localisation of the protein to the periphery of the cell was, however, dependent on the C-terminus of BCR/ABL PTK. Deletion of the C-terminus reversed both BCR/ABL-mediated apoptotic suppression and drug resistance although the progenitor cells did retain a proliferative advantage at low concentrations of growth factor. These results demonstrated that the C-terminal actin-binding domain of BCR/ABL is important for some of BCR/ABL PTK-mediated leukaemogenic effects.

U2 - 10.1111/j.1365-2141.2005.05949.x

DO - 10.1111/j.1365-2141.2005.05949.x

M3 - Journal article

VL - 132

SP - 774

EP - 783

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 6

ER -